+49 711 500 989 80
deen

For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones



For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones

Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

Materials provided by Oregon State University. Original written by Steve Lundeberg. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th May 2022

High cost of cancer care in the U.S. doesn't reduce mortality rates

Read more
27th May 2022

T cell warriors need their R & R

Read more
27th May 2022

New cancer subtype may illuminate treatment strategy

Read more